Milky Mist Dairy up 5.0% after commissioning ₹40 crore high-protein yogurt plant

In a press release dated September 10, 2026, Milky Mist said it has commissioned a "new state-of-the-art Skyr and Greek Yogurt manufacturing plant using Ultrafiltration Technology" at its integrated manufacturing facility in Perundurai, Tamil Nadu (page 2).

Key details from the filing:

• The plant has been built with an investment of "approximately ₹40 crore" (page 2).
• The new exclusive plant has "a processing capacity of up to 150 tonnes per day" (page 2).
• Milky Mist first introduced ultrafiltration technology for Skyr and Greek yogurt in 2022, positioning itself early in high-protein nutrition (page 2).
• The facility is part of the company’s broader expansion and modernisation programme at Perundurai, which the filing notes is "one of the stated objects of the Company’s initial public offering" (page 2).

The press release also highlights that the facility was developed after "an extensive evaluation of global manufacturing technologies" and that its ultrafiltration capabilities are expected to support higher production volumes, consistent product quality and differentiated high-protein offerings (page 2).

The market’s 5.0% move appears tied to two elements the filing and live commentary both underscore:

1. A sharp jump in capacity in a fast-growing niche
2. Alignment with Milky Mist’s premium, value-added strategy

On capacity, the company reminds investors that it installed a customised multi-product yogurt facility in 2022 "with a capacity of about 20 tonnes per day" (page 2). Against that base, the new Skyr and Greek yogurt plant at 150 tonnes per day represents a substantial scale-up for this specific high-protein sub-category.

The filing links this directly to demand trends:

• Since 2022, "annual demand for the category has grown by more than 50%" (page 2).
• Milky Mist has "witnessed demand for high-protein yogurts more than double in recent months" (page 2).

That combination – more than 50% annual category growth and demand for high-protein yogurts more than doubling recently – helps explain why traders were willing to pay up for the stock when the market opened after the announcement. The new plant gives Milky Mist the physical capacity to convert that demand into revenue in a segment where pricing power and margins are typically better than in commoditised liquid milk.

The press release positions the new facility as part of a broader strategic arc rather than a one-off project.

Chief executive Dr. K Rathnam is quoted as saying that "high-protein nutrition is moving from a niche preference to an increasingly mainstream consumption trend" and that the strong growth in Skyr and Greek yogurt "validates our early investment in this category" (page 3).

He adds that with processing capacity of up to 150 tonnes per day, the plant "provides us with the scale to serve rising demand, accelerate innovation and expand the category" and that the investment "creates a robust platform for sustained profitable growth" (page 3).

For investors who have already seen Milky Mist’s recent revenue acceleration, that language matters. The company notes in the same document that its revenue "grew at a CAGR of 31.26% between FY2024 and FY2026, reaching Rs. 3,138.36 crore in FY2026" (page 3). While the filing does not break out margins or profitability for the Skyr and Greek yogurt line, it explicitly frames this plant as part of its "high-growth value-added dairy category" focus (page 2).

The live market commentary also emphasises that this expansion is in "high-demand, value-added dairy products" and that it "is expected to fuel future revenue growth" in premium segments. That dovetails with the company’s own description of itself as "a leading value added dairy and packaged food company in India" with 22 product categories and "640+ SKUs" as of June 30, 2026 (page 3).

Another reason the stock likely found buyers: the project is explicitly tied to IPO use-of-proceeds. The filing states that the facility "forms part of Milky Mist’s broader expansion and modernisation programme at Perundurai - one of the stated objects of the Company’s initial public offering" and that its commissioning "represents the translation of the Company’s capital investment programme into operational capacity" (page 2).

For investors who subscribed to the IPO on the promise of capacity-led growth in value-added dairy, seeing a ₹40 crore ultrafiltration plant up and running is a tangible milestone. It suggests the company is executing on its capex roadmap rather than merely planning it.

The press release is operational and strategic; it does not provide:

• Any immediate revenue or profit guidance linked to the new plant.
• Segment-wise margin data for Skyr and Greek yogurt.
• Timelines for ramp-up to the full 150 tonnes per day.

It also does not quantify how much of the existing 20 tonnes per day capacity will be repurposed or how the new facility will change the product mix within the broader yogurt portfolio.

That leaves some uncertainty around how quickly the ₹40 crore investment will translate into earnings. However, the stock’s 5.0% rise to Rs 293 suggests the market is currently focused on the direction of travel – more capacity in a category where demand has grown by more than 50% annually – rather than on near-term return-on-capital metrics.

Milky Mist shares had already been in focus after recent disclosures highlighted rapid revenue growth and the benefits of premium products. This latest commissioning update extends that narrative into the high-protein yogurt niche, giving investors a concrete asset – a 150 tonnes per day ultrafiltration plant backed by ₹40 crore of capex – to anchor expectations of future growth.

As always, the filing itself is careful to include a standard safe-harbour statement that forward-looking comments are subject to risks and uncertainties and "are not necessarily predictive of future results" (page 3). For now, though, the market appears willing to pay for the option value embedded in Milky Mist’s expanded high-protein platform.